Sowmya Chary

Sowmya Chary is a Senior Medical Director in Clinical Development at Dyne Therapeutics since August 2025. Additionally, Sowmya Chary serves as a Faculty Course Director for courses focused on Translational Investigation and Drug Development at Harvard Medical School since February 2021. Previous roles include Medical Director in Clinical Development and Global Medical Safety at Biogen, where responsibilities encompassed Multiple Sclerosis and Immunology, as well as Neuromuscular and Movement Disorders. Sowmya Chary’s earlier experience includes positions at Takeda, Brigham and Women's Hospital, and Lawrence General Hospital. Educational qualifications include a Doctor of Medicine from Sri Ramachandra Institute Of Higher Education and Research, various degrees from Harvard Medical School, and a Master of Health Care Delivery Science from Dartmouth College.